Skip to main content
Premium Trial:

Request an Annual Quote

Stem Cells and Cloning: Ingredients for a Real Debate

A couple of wire stories today relate to bills in US Congress on stem cells and human cloning. One details the defeat of a bid to outlaw cloning of human babies by mostly Republican legislators who argued that while the goal was good, the bill itself was flawed.

The other bill, which aims to loosen restrictions on federally funded embryonic stem cell research, looks like it will pass the US House of Representatives, according to this story. But the article notes that President Bush has already promised to veto the bill, and it's unclear whether there are enough supporting votes in Congress to overturn that.

 

The Scan

Could Cost Billions

NBC News reports that the new Alzheimer's disease drug from Biogen could cost Medicare in the US billions of dollars.

Not Quite Sent

The Biden Administration likely won't meet its goal of sending 80 million SARS-CoV-2 vaccine doses abroad by the end of the month, according to the Washington Post.

DTC Regulation Proposals

A new report calls on UK policymakers to review direct-to-consumer genetic testing regulations, the Independent reports.

PNAS Papers on Mosquito MicroRNAs, Acute Kidney Injury, Trichothiodystrophy

In PNAS this week: microRNAs involved in Aedes aegypti reproduction, proximal tubule cell response to kidney injury, and more.